$41.96
0.531.28%
Pré-commercialisation: Jun 12, 4:14 PM EDT
SPDR S&P Pharmaceuticals ETF (ARCA: XPH)
Ticker | Name | Share % | |
---|---|---|---|
AXSM | Axsome Therapeutics, Inc. | 3.81% | |
VTRS | Viatris Inc. | 3.82% | |
ITCI | Intra-Cellular Therapies Inc | 3.60% | |
BMY | Bristol-Myers Squibb Co. | 3.65% | |
PFE | Pfizer, Inc. | 3.67% | |
CORT | Corcept Therapeutics Inc | 5.67% | |
JNJ | Johnson & Johnson | 3.83% | |
OGN | Organon & Co | 3.55% | |
CTLT | Catalent, Inc. | 3.84% | |
ZTS | Zoetis, Inc. | 4.19% | |
RPRX | Royalty Pharma | 4.02% | |
LLY | Eli Lilly & Co. | 3.61% | |
JAZZ | Jazz Pharmaceuticals Plc | 4.19% | |
PRGO | Perrigo Co. Plc | 3.92% | |
TARS | Tarsus Pharmaceuticals Inc | 4.11% | |
ELAN | Elanco Animal Health Inc. | 5.20% | |
PBH | Prestige Consumer Healthcare Inc | 3.92% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
XPH suit un style d'investissement Mid Cap Blend.
Les principales positions de XPH incluent : AXSM (3.81%), VTRS (3.82%), ITCI (3.6%), BMY (3.65%), PFE (3.67%). Il s'agit des plus grandes positions dans le portefeuille de l'ETF.
Les données du volume moyen quotidien pour XPH ne sont actuellement pas disponibles.